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Abstract Setting:The Southwest of Ireland (Counties Cork and Kerry) 1987^2000, average population 549500. Ob-
jective:Nontuberculousmycobacteria (NTM) cause significantmorbidity worldwide and the studyof epidemiology and
characteristics helps in their prevention and treatment.This study was performed to determine the incidence of NTM
disease in comparison to Mycobacterium tuberculosis (M. tuberculosis) and Mycobacterium bovis (M. bovis) in Southwest
Ireland, over the above time period.Design:Aretrospective study was carried out in all human isolates of NTM,M. tu-
berculosis andM. bovisbetween1987 and 2000, in the Southwest Region of Ireland.Results:Themeanincidence of NTM
(0.4/100 000 population) hasrisen since1995, principallyof pulmonaryMycobacteriumaviumintracellulare complex (MAC).
The annual incidence of M. tuberculosis in humans over 14 years in the same region was 9.71/100 000 population with a
significant reduction since1994 andM. bovis remained constant at 0.5/100 000 population.Conclusion:The increasing in-
cidence of disease causing NTM noted in Southwest Ireland reflects global data and is surmised to be due to an ageing
population, increasedincidencerelatedto chronic fibrotic lungdisease, andenvironmentalmycobacterial factors. r2002
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Nontuberculous mycobacteria (NTM) have been recog-
nised, since the early1950s in theU.S.A. (1) as causingdis-
ease in humans. These organisms are variously referred
to as opportunist, environmental, and mycobacteria
other than tuberculosis.
NTM infection is commonly acquired from environ-
mental sources including water and soil, fromwhich they
have been isolated. Mycobacterium avium intracellulare
complex (MAC), theNTMmost studied, has been identi-
¢ed in animals, but animal to human transmission is
deemed unimportant as suggested by serological and
plasmid analysis (2^4). These organisms are not always
pathogenic when isolated from human samples, and the
identi¢cation of which isolates are disease causing and
which are contaminants or colonisers is based on inter-
nationally recognised criteria (9,10). Most immunocom-Received10 June 2002, accepted in revised form12 August 2002.
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these organismswithout tissue invasion occurring.
Common NTM pulmonary infections are noncavita-
tory, often complicating chronic lung ¢brosis of varying
aetiology, chronic obstructive airways disease, and
bronchiectasis. The common NTM extrapulmonary in-
fections are benign cervical adenopathy in children (5),
skin lesions, and disseminated disease in the immuno-
compromised person. In developed countries, NTM in-
fection can also cause diverse infections including
tenosynovitis (4,6), skeletal infection, arthritis, bursitis,
tendon sheath infection, otomastoiditis (7), and pro-
sthetic tissue infection (8). Disseminated MAC is a
common bacterial infection in patients with acquired
immune de¢ciency syndrome (AIDS), occurring in
20^40% of all patients in several reported series prior
to the advent of highly active antiretroviral therapy
(HAART) (9).
The NTM organisms that can cause human disease
include MAC, Mycobacterium kansasii, M. marinum, M.
malmoensae,M. abscessus,M. ulcerans,M. xenopi,M. for-
tuitum-cheloni,M. szulgai,M. simiae, andM. scrofulaceum.
We initiated a study to assess the extent of disease
caused by NTM over a14-year period from1987 to 2000
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tion of incidence of NTMwithM. tuberculosis andM. Bo-
vis, to identify the type of infections caused, to identify
the NTM isolates involved, and to assess the patients
demographic characteristics of patients infected by this
disease.
MATERIALSANDMETHODS
The catchment area, the Southwest Ireland (Southern
Health Board Region comprising Counties Cork and
Kerry), is both urban and rural with a predominantly
indigenous Caucasian population with a minority of
other ethnic races (less than 1% combined African,
Eastern European, and Asian). The population in 1986
was 536900 and increased to 563 000 by the end of
2000 (average approximately 550 000). The population
over 65 increased from less than 60 000 in 1987 to
66900 at the end of 2000. The temperate climate of
the area has an average annual temperature of 91C.
The annual number of days with more than 1mm of
rain is approximately 200 in the Southwest part of the
country.
NTM isolates in Southwest Ireland between1987 and
2000were identi¢ed.Onlyhuman isolateswere included.
The sources of the samples included all the hospitals in
the above area, aswell as sputum samples sent indirectly
from General Practitioners. Clinical samples were ana-
lysed at the Regional Medical Microbiology Laboratory
in Cork University Hospital. The Medical Microbiology
Laboratory in Cork University Hospital is the main
microbiology laboratory for a number of hospitals in
Cork City, but also acts as a referral laboratory for
specimen analysis for all other hospitals in the Health
Board region.
All dataweregathered from theCorkUniversityHos-
pital Medical MicrobiologyDatabase, which included pa-
tient identi¢cation, anatomical source of sample, and
information on the decision to treat. Repeated positive
isolates from the same site in a single individual were
counted as one in data analysis.
The decision to treat in our population was based on
consultation between the responsible clinician and the
microbiology team.
NTM isolates were considered disease causing
if they ful¢lled the criteria established in 1990 by
the American Thoracic Society for NTM disease (9).
The criteria for pulmonary disease are brie£y as
follows:
1. Greater than or equal to two sputum specimens (or
one sputum and one bronchial washing specimen)
that are smear-positive for acid fast bacilli (AFB) or
that yieldmoderate to heavy growth culture.
2. Exclusion of other reasonable causes of the disease
processes.Alternatively, the followingmay be diagnostic:
1. A tissue biopsy specimen that yields NTM in culture
and has consistent histopathological features.
2. Tissue biopsy specimens that are culture-negative but
contain granulomas or AFB, when two previously
obtained sputum/bronchial-washing specimens have
been culture-positive.
Skin/soft tissue disease was identi¢ed if a culture of a
swab or biopsy specimen of a lesion involving skin, sub-
cutaneous tissue, muscle, or synoviumyieldedNTM.
Disseminated disease was identi¢ed if the causative
species was isolated from blood or bonemarrow.
Lymphadenitis was identi¢ed if culture of a biopsy spe-
cimen or swab of a clinically pathological lymph node
yieldedNTM.
The criteria for diagnosis of disease caused by NTM
has been revised in the 1997 AmericanThoracic Guide-
lineswith stricter bacteriological, radiographic, and clin-
ical criteria (10).
All cases of NTM deemed contaminants or colonisers
were cultured fromurine, sputum, or bronchialwashings
where repeat samples were not clinically indicated or
were negative, and treatment was not considered by
the responsible clinician in consultation with the micro-
biology laboratory. AllM. tuberculosis andM. bovis cases
were deemed disease causing.
Until January 1998, all samples of Mycobacteria were
cultured on Lowenstein Jensen Medium, supplemented
with pyruvic acid. Since 1998, Middlebrooks Liquid Cul-
ture using a Camlic (Continuous Automated Monitored
Liquid Culture) system has been used. Thiosemicarbi-
zone,TCH (thiopen2carboxylicacid hydrazine), and p-ni-
trobenzoic acidmedia are used to identify organisms.
All statistical analyseswere carriedoutusingunpaired
t-test. A signi¢cant value of less than 0.05 was used.
RESULTS
In total, there were 960 mycobacterial (M. tuberculosis,
M. bovis andNTM) isolates over the14-year period. Eight
hundredand seventeen of the total 960 isolatesweredis-
ease causing, the remaining 143 were considered con-
taminant or colonising NTM.This is highlighted inTable1.
Figure 1 plots the incidence of M. tuberculosis and M.
bovis in the study population.
Of the 817 total culture positive isolates, 749 (91.6%)
were due toM. tuberculosis.Themean incidence ofM.tu-
berculosis was 53.5(78.7SD), 9.72/100 000 population per
year.This incidencehas signi¢cantlydropped since1993 (P
= 0.004).The incidence in 2000 was 7.94/100 000.Of the
M. tuberculosis isolates 37.5% were female patients (mean
age 55 years) and 62.5% weremale (mean age 46 years).
The total number of M. bovis cases was 36. The
incidence of M. bovis remained stable until 1999 with an
TABLE 1. Totalnumberofmycobacteria isolates in Southwest Ireland,1987^2000
Mycobacterium Disease causing Contaminantorcoloniser Total
MTB 749 (78%) 0 749 (78%)
MBOVIS 36 (4%) 0 36 (4%)
NTM 32 (3%) 143 (15%) 175 (18%)
Total 817 (85%) 143 (15%) 960 (100%)
MTB =M. tuberculosis;MBOVIS =M. bovis;NTM =Nontuberculousmycobacteria.
FIG. 1. Incidence of NTM,M. tuberculosis, andM. bovis in the Southwest Ireland,1987^2000.MTB =M. tuberculosis,MBOVIS =M.
bovis.
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Fifty per cent of M. bovis cases were male (mean age 53
years) and 50% were female (mean age 63 years). Fifty-
three per cent of M. bovis cases were pulmonary and
47% were extra pulmonary.
One hundred and seventy-¢ve isolates of NTM were
grown, of which 143 were considered contaminants or
colonisers and 32 disease causing. Table 2 highlights the
breakdown of NTM into disease-causing isolates and
contaminants or colonisers.
The mean incidence of disease-causing NTM was 0.4/
100 000/year; Fig. 2 plots the trend of incidence of dis-
ease-causing NTM over the 14-year period. Our dis-
ease-causing NTM-to-M. tuberculosis ratio was 4.3% for
the 14-year period. The ratio of disease-causing isolates
to contaminant/colonising NTM over the14-year period
was18%.
Fifty per cent of disease-causing NTM cases were
male. The average male age was 32, female age was 48,
and the average total age of disease-causing NTM cases
was 40.
Fifty-three per cent of disease-causing NTM cases
were pulmonary. Forty-seven per cent were extrapul-monary including 10 cases (31%) involving skin, three
cases (9%) of lymph node involvement, one case of paro-
tid gland in¢ltration (3%), and one culture from bone
marrow (3%) (seeTable 3).The di¡erencebetween actual
initial skin involvement and breakdown from deeper
lymph node involvement was di⁄cult to elucidate from
documentation and it is probable that some of the MAC
isolates from skinwere lymph node abscess breakdown.
Of the 32 cases of NTM considered disease causing,
therewere 23 MAC cases (2.8% of the total 831disease-
causing mycobacterial isolates), ¢veM. malmoense cases
(0.6%), two M. abscessus cases (0.22%), one M. marinum
case (0.1%), and oneM. kansasii case (0.1%).
Therewas a statistically signi¢cant increase in disease-
causing NTM infection since and excluding 1994, P value
= 0.01, with 20 cases occurring in the 6 years since 1995
inclusive and 12 cases occurring in the 8 years prior to
and including 1994, the increase being principally in pul-
monary disease. Of these 20 NTM cases since 1994, 16
were MAC, 11 pulmonary, and ¢ve extrapulmonary.
There were three pulmonary MAC cases prior to 1994.
Two pulmonaryM. malmoense cases occurred since1995
and one prior to this.





Disease-causing NTM 32 3
MAC 23 2
M. malmoense 5 0.5
M. abscessus 2 0.2
M. marinum 1 0.2
M. kansasii 1 0.1
Contaminant/colonising NTM 143 15
M. fortuitum 27 3
M. gordonae 27 3
M. terrae 26 3
M. chelonae 20 2
Envir. Scotochromogens 19 2
MAC 13 1
M. xenopi 5 0.5
M. £avescens 2 0.2
B.C.G. 2 0.2
M. malmoense 1 0.1
Unclassi¢ed 1 0.1
NTM = nontuberculous mycobacteria; MAC = M.
avium intracellulare; Envir. Scotochromogens = Environ-
mental Scotochromogens; B.C.G. = Bacille Calmette-
Guerin.
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in Southwest Ireland was MAC.Of the total of 36 MAC
isolates, 23 (64%) were disease causing. The contami-
nant/colonising MAC cases were all from single sputum
specimens. Sixty-one per cent of the disease-causingFIG. 2. Disease-causingNTMisolatesin Southwest Ireland,1987^
lates.MAC isolates were from pulmonary specimens. The
mean incidence of disease-causing MACwas1.6 (71.1SD),
0.3/100 000 population per year. Three cases of MAC
were AIDS associated, one prior to 1995, one in 1999,
and one in 2000.One of these was isolated from a bone
marrow sample signifying disseminated disease and two
were pulmonary isolates.
Since the introduction of the newer culturemethod in
1998, therewas a statistically insigni¢cant increase in dis-
ease-causingNTMdisease identi¢ed (P =0.16).Therewas
a statistically insigni¢cant increase in total NTM isolates
since1995 (P = 0.15) and1998 (P = 0.13).
Therewere two peaks inM. chelonae culture, both of
which arose frombronchoscope colonisation in separate
hospitals. One of these peaks occurred in 1992 and the
other in 2000. FiveM. xenopi isolates have been isolated
since 1999 from various geographical locations. Both
B.C.G. (Bacille Calmette-Guerin) isolates were in urine
samples during transitional cell bladder tumour treat-
mentwith B.C.G.
DISCUSSION
NTM disease is not reported in many countries making
reliable estimates of its incidence di⁄cult. Despite this,
in a number of population studies inmanydi¡erent coun-
tries, there has been a rise in the incidence of NTM-re-
lated disease over the last15 years.Worldwide incidence
is also hamperedby a lack of uniformity of de¢ning NTM
disease.
The incidence in our study population, at 0.4/100 000
from 1987 to 2000 and from 1995 to 2000 at 0.62/
100 000, is comparable to the Zurich study from1983 to2000.NTM=Disease-causingnontuberculousmycobacterial iso-
TABLE 3. Site of NTMdisease in Southwest Ireland,1987^2000
NTM Pulmonary Extrapulmonary Lymphnode Skin Other Total
MAC 14 9 2 5 2a 23
M. malmoense 2 3 1 2 0 5
M. marinum 0 1 0 1 0 1
M. kansasii 0 1 0 1 0 1
M. abscessus 1 1 0 1 0 2
Total 17 (53%) 15 (47%) 3 (9%) 10 (31%) 2 (7%) 32(100%)
aOneparotidglandinfection, onebonemarrowinfectionindicatingdisseminateddisease in animmunocompromisedpatient.
NTM= nontuberculousmycobacteria;MAC =M. aviumintracellulare.
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found in North Australia from 1989 to 1997 (3.9 cases/
100 000 in the general population, 2.1 cases/100 000 in
human immunode¢ciency virus negative patients, this
study was used the 1990 American Thoracic Society
criteria) (12) and in the U.S.A. from 1981 to 1983 1.8/
100 000 (13).
There appears to be a considerable amount of varia-
tion throughout the world in relation to the strain of
NTM found.MAC (predominantlypulmonary) wasmore
predominant in North Australia (12), U.S.A. (13), South-
East of England (14), Liverpool (15), and M. kansasii was
more common in South Africa (16), a Netherlands coal
mining population (17), M. ulcerans in West Africa (18),
and M. fortuitum was more common in Taiwan (19). A
Scottish review from 1990 to 1993 found a surprisingly
high incidence ofM.Malmoense pulmonary disease (20).
The variation in percentage of disease-causing isolates
to total isolates, 18% in the Southwest of Ireland (1987^
2000), 6.6% in the Zurich study (1983^1988), and 42% in
theTaiwan study (1992^1996), is related to a number of
factors including reporting, de¢nition of disease, and la-
boratory technique.
In contrast to a lower incidence of NTM in the South-
west of Ireland, there is still a relatively high incidence of
M. tuberculosis in comparison to Europe and the United
States. A study in Sweden indicated that B.C.G. vaccina-
tion might play a role in protection against disease
caused by NTM (21) having relevance in Ireland, where
B.C.G. vaccination in childhood ismandatory.Previous la-
boratory data have also suggested that cross-immunity
between species may exist, and a reduction in incidence
ofM. tuberculosismay lead to a mycobacteria-susceptible
population (22).
Fibrotic lung disease is a risk factor for the develop-
ment of pathogenic NTM disease, although there
is increasing evidence of pulmonary disease in immuno-
competent patients without prior lung disease (23).
Although industrial lung disease is uncommon in South-
west Ireland, ¢brotic lung disease secondary to pulmon-
ary tuberculosis is prevalent BCG vaccination is
mandatory inmany districts.The increasing incidence of NTM from di¡erent geo-
graphical locations is due in part to increased sensitivity
of methods of detection, although the incidence in the
Southwest of Ireland began to increase prior to the in-
troduction of the newer culture system.We can there-
fore assume that this did not signi¢cantly a¡ect the data
observed. Future development of DNA analysis and
skin testing will help improve the sensitivity of mycobac-
terial detection. One such method has been previously
reviewed in the same population (24). Increasing inci-
dence may also re£ect an increased awareness by hospi-
tal medical sta¡ and general practitioners of NTM
infection.
The ageingpopulation in the Southwest of Irelandmay
also be a factor in the increasing incidence of NTM.The
population over 65 increased from less than 60 000 in
1987 to 66900 at the endof 2000 in the Southwestof Ire-
land.The lower average population age in the Southwest
of Ireland (40 years) than in the Australia (age 57 in pul-
monary nonHIV cases) and Liverpool (61.5) studies, and
suggested by the Southeast of England Geriatric group,
mayre£ect a bias by physicians not to diagnose and treat
older patients. Inclusion of skin and lymphadenopathy
cases in our analysis of age also reduces the age average
in comparisonwith the above two groups.
Sexdistributionwas equal in ourpopulation, 64%male
in the Liverpool study and 71% male in the Australia
study; the predominance of nonHIV-related pulmonary
NTM was thought to be associated with higher rates of
chronic lungdisease also reduces the age average in com-
parisonwith two of the above groups.
The increasing incidence in our population does not
appear to be AIDS related.Three cases in total of signi¢-
cantNTMwere found to beAIDSrelated, two since1995
andoneprior to1995.The incidence ofAIDS is decreasing
in the Republic of Ireland (6.8 per million population in
1999 compared to11.9 in Britain, 77.1in Spain for the same
year) (25).The incidence of AIDS de¢ning illness, includ-
ing MAC, has decreased dramatically from 30.7/100 pa-
tient^years during1994 to 2.5/100 patient^years in 1998
in Europe (26) with similar ¢ndings in the U.S.A. (27).
The advent of HAART therapy is the most important
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re£ect a higher incidence ofAIDS-associatedNTMinfec-
tion not identi¢ed in the data analysed.
Other factors responsible for the increasing incidence
of signi¢cant NTM may be external factors causing
either changes in the distribution or virulence of myco-
bacteria in the environment; NTM has shown to be iso-
lated from areas where water temperatures are high
(28).
The isolation and eradication of one of theM. chelonae
bronchoscopy outbreaks has been described previously
(29). The ¢ve M. xenopi isolates grown since 1999 were
from various geographical locations. A previous report
highlighted hospital water system contamination as a
cause of increasedM. xenopi isolation (30).
The incidence of M. bovis remained stable until 1999,
similar to a previous study ofM.Bovis from the same po-
pulation (31).
In conclusion, the increasing incidence of NTM in the
Southwest of Ireland, principally in pulmonary MAC dis-
ease, over the past 14 years, re£ects trends from other
population analyses from other countries hamperedby a
lack of uniformity of de¢ning disease-causing NTM iso-
lates and lack of adequate surveillance data. It may re-
£ect an ageing population that is more susceptible to
infection, although the average age of diagnosis is less
than in other cited studies and increasing re£ection of ¢-
brotic lung disease in the area secondary toM.tuberculo-
sis, withreducing incidence of newM. tuberculosis disease
leading to less cross-immunity. It may also re£ect envir-
onmentalmycobacterial factors, with the cooler climate
possibly explaining a slower rise in NTM disease in the
Southwest of Ireland that in other analysis mentioned.
Both detection methods and AIDS incidence
appear not to have in£uenced our data. Further study
of the epidemiology, source, and disease caused by
NTM will help in its prevention and help identify
patients in whom early aggressive therapy will improve
outcome.
REFERENCES
1. Lewis AG, Lasche EM, Armstrong L, Dunbar FP. A clinical study of
the chronic lung disease due to nonphotochromogenic acid-fast
bacilli. Ann Intern Med 1960; 53: 273–285.
2. Meissner G, Anz W. Sources of Mycobacterium avium complex
infection resulting in human disease. Am Rev Respir Dis 1977; 116:
1057–1064.
3. Ahrens P, Giese SP, Klausen J, Inglis NF. Two markers, IS901 –IS902
and p40 identified by PCR and by using monoclonal antibodies in
Mycobacterium avium strains. J Clin Microbiol 1995; 33: 1049–1053.
4. Kiely JL, O’Riordan DM, Sheehan S, Curtin J, Hogan J, Bredin CP.
Tenosynovitis due to mycobacteria other than tuberculosis: a
hazard of water sports and hobbies. Respir Med 1995; 89: 69–71.
5. Flint D, Mahadevan M, Barber C, Grayson D, Small R. Cervical
lymphadenitis due to non-tuberculous mycobacteria: surgical
treatment and review. Int J Pediatr Otorhinolaryngol 2000; 53:
187–194.6. Zenone T, Boibieux A, Tigaud S, Fredenucci JF, Vincent V, Chidiac
C, Peyramond D. Non tuberculous mycobacterial tenosynovitis: a
review. Scand J Infect Dis 1999; 31: 221–228.
7. Flint D, Mahadevan M, Gunn R, Brown S. Nontuberculous
mycobacterial otomastoiditis in children: four cases and a literary
review. Int J Pediatr Otolaryngol 1999; 51: 121–127.
8. Heisten JB, Mangino JE, Ruberg RL, Bergese JJ. A prosthetic breast
implant infected with Mycobacteriumfortuitum. Ann Plast Surg 2000;
44: 330–333.
9. American Thoracic Society. Diagnosis and treatment of disease
caused by Nontuberculous Mycobacteria. Am Rev Respir Dis 1990;
142: 940–953.
10. American Thoracic Society. Diagnosis and treatment of disease
caused by Non Tuberculous Mycobacteria. Am J Respir Crit Care
Med 1997; 156: S1–S25.
11. Debrunner M, Salfinger M, Brandli O, and von Graevenitz A.
Epidemiology and clinical significance of nontuberculous myco-
bacteria in patients negative for human immunodeficiency virus in
Switzerland. Clin Infect Dis 1992; 15: 330–345.
12. O’Brien DP, Currie BJ, Krause VL. Nontuberculous mycobacterial
disease in northern Australia: case series and review of the
literature.Clin. Infect.Dis. 2000; 31: 958–967.
13. O’Brien RJ, Geiter LJ, Snider DE. The epidemiology of
nontuberculous mycobacteria diseases in the United States: results
from a national survey. Am.Rev. Respir.Dis. 1987; 135: 1017–1014.
14. Kennedy TP, Weber DJ. Nontuberculous mycobacteria. An under
appreciated cause of geriatric lung disease. Am J Respir Crit Care
Med 1994; 149: 1654–1658.
15. Corless JA, Stockton PA, Davies PD. Mycobacterial culture results
of smear-positive tuberculosis in Liverpool. Eur Respir J 2000; 16:
976–979.
16. Corbett EL, Blumberg L, Churchyard GJ, et al. Nontuberculous
mycobacteria: defining disease in a prospective cohort of South
African Miners. Am J Respir Crit Care Med 1999; 160: 15–21
17. Cerda de Palou E, Sulzer MA, van Noord JA. [Indications for an
increase in lung disease caused by Mycobacterium Kansasii in the
former Limburg mining area.] Dutch. Ned Tijdschr Geneeskd 1995;
139: 1231–1236.
18. Van der Werf TS, van der Graaf WT, Tappero JW, Asiedu K. My-
cobacteriumulcerans infection. Lancet 1999; 354: 1013–1018.
19. Shih JY, Hseuh PR, Lee LN, Wang HC, Yang PC, Kuo SH, Luh KT.
Nontuberculous mycobacteria isolates clinical significance and
disease spectrum. J Formos Med Assoc 1997; 96: 621–627.
20. Bollert FG, Watt B, Greening AP, Crompton GK. Non-
tuberculous pulmonary infections in Scotland: a cluster in Lothian?
Thorax 1995; 50: 188–190.
21. Romanus V, Hallander HO, Wahlen P, Olinder-Nielsen AM,
Magnusson PH, Juhlin I. Atypical mycobacteria in extrapulmonary
disease among children. Incidence in Sweden from 1969 to 1990,
related to changing BCG vaccination coverage. Tuber Lung Dis
1995; 76: 300–310.
22. Youmans GP, Youmans YA. The measurement of the response of
immunised mice to infection with Mycobacterium tuberculosis var.
hominis. J Immunol 1957; 78: 318–329.
23. Olivier KN. Nontuberculous mycobacterial pulmonary disease.
Curr.Opin. PulmMed 1998; 4: 148–153.
24. O’Connor TM, Sheehan S, Cryan B, Brennan N, Bredin CP. The
ligase chain reaction as a primary screening tool for the detection
of culture positive tuberculosis. Thorax 2000; 55: 955–7.
25. O’Donnell K, Cronin M, Igoe D. Review of Epidemiology of AIDS
in Ireland (1983–1999). A report by the National Disease
Surveillance Centre 2000; 21–22.
26. Morcroft A, Katlama C, Johnson AM, et al. AIDS across Europe,
1994–1998: the EuroSIDA study. Lancet 2000; 356: 291–296.
27. Kaplan JE, Hanson D, Dworkin MS, et al. Epidemiology of human
immunodeficiency virus-associated opportunistic infections in the
NONTUBERCULOUSMYCOBACTERIAINSOUTHWEST IRELAND 263United States in the era of highly active antiretroviral therapy. Clin
Infect Dis 2000; 30 (Suppl 1): S5–S14.
28. Gruft H, Falkinham JO, Parker BC. Recent experience in the
epidemiology of disease causes by atypical mycobacteria. Rev Infect
Dis 1981; 3: 990–996.
29. Kiely JL, Sheehan S, Cryan B, Bredin CP. Isolation of Mycobacter-
ium chelonae in a bronchoscopy unit and its subsequent
eradication. Tubercle and Lung Dis 1995; 76: 163–167.30. Costrini AM, Mahler DA, Gross WM, Hawkins JE, Yesner R,
D’Esopo ND. Clinical and roentgenographic features of nosoco-
mial pulmonary disease due to Mycobacteriumxenopi.Am.Rev.Respir
Dis. 1981; 123: 104–109.
31. Cotter TP, O’Shaughnessy E, Sheehan S, Cryan B, and Bredin CP.
Human Mycobacteriumbovis infection in the south-west of Ireland
1983–1992: a comparison with Mtuberculosis. IrishMed J 1996; 89:
62–63.
